Company Short-Term Debts: Delcath Systems (DCTH)

Graphic logo of Delcath Systems, Inc. (DCTH)

This price chart illustrates the price action of Delcath Systems, Inc. (DCTH), where the specific short-term debt metric stands at 0.00. The expansion of the medical center network utilizing the company's consumables is driving profit growth by reducing the impact of previous R&D expenditures. The business develops innovative tools for targeted liver treatment, enabling the company to maintain significant pricing power due to a lack of competing solutions.

Company Short-Term Loans and Borrowings: Delcath Systems Inc (DCTH) for 07/04/2022 - 10/28/2026

DCTH (Delcath Corp): analytical breakdowns and indicator data

- price and consensus price forecast:
Stock Price Delcath Systems|DCTH - Consensus Target
- market capitalization data:
Market Capitalization Delcath Systems, Inc.|DCTH - Total Enterprise Value
- book capitalization data:
Net Assets per Single Share Delcath Systems|DCTH - Accounting Value of Company|Market Cap to Net Assets Ratio delcath.com|DCTH - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Delcath Systems, Inc.|DCTH - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio Delcath Systems, Inc.|DCTH - Company Aggregate Debts|Debt to Book Capitalization Ratio Delcath Systems, Inc.|DCTH - Company Long-Term Loans and Borrowings|Company Short-Term Debts Delcath Systems
Fundamental company valuation:DCTH Delcath Systems
Flagship merchandise of delcath.com

The financial stability of Delcath Systems, Inc. (DCTH) is based on effective liquidity management during the market rollout of the Hepzato Kit. Total current liabilities reflect the aggregate of all obligations due within one year. The trend of this metric demonstrates the company's ability to service loans without compromising its proprietary development. A reduction in the debt load confirms the operational stability of the business. The control of these payments directly impacts the calculation of the fair value of the shares.

Competitors of Delcath Systems, Inc. (DCTH)

ONC: Company Short-Term Debts|HALO - Company Current Liabilities|Company Short-Term Debts RVMD|AAPG (Ascentage Pharma Corp) - Short-Term Debt|CGON - Company Short-Term Debt|Company Short-Term Loans and Borrowings urogen.com (URGN)|Bicara Therapeutics (BCAX) - Company Current Liabilities|Company Short-Term Loans and Borrowings Personalis Inc (PSNL)|Erasca Corp - Company Short-Term Debts|YMAB - Company Current Liabilities|Aura Biosciences, Inc. - Company Current Liabilities|CADL: Company Short-Term Debts|Company Short-Term Debt Accuray ARAY|SELLAS Life Sciences Group (SLS) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ACTU (Actuate Therapeutics, Inc)|Short-Term Debt Citius Oncology Inc|Company Short-Term Debts TuHURA Biosciences, Inc. HURA|Company Short-Term Indebtedness protaratx.com (TARA)|FATE: Company Short-Term Debts|Aadi Bioscience, Inc. - Short-Term Debt|TCRX - Company Short-Term Debt|CSBR - Company Short-Term Debt|XBIT (xbiotech.com) - Company Short-Term Debts|CEL-SCI (CVM) - Company Current Liabilities|OSTX (OS Therapies) - Company Short-Term Debts|Company Short-Term Debts Radiopharm Theranostics Ltd (RADX)|Company Current Liabilities Artiva Biotherapeutics, Inc.|Amount of Current Liabilities adlainortye.com (ANL)|Company Short-Term Debts Veru Inc.|TPST - Company Short-Term Loans and Borrowings|Company Current Liabilities Xilio (XLO)|RENB: Company Short-Term Loans and Borrowings|muraloncology.com - Company Short-Term Debt|Short-Term Debt Volume Kairos Pharma|Company Current Liabilities OKUR (OnKure Therapeutics, Inc.)|Short-Term Debt GDTC|CRIS (Curis, Inc.) - Company Short-Term Debt|Short-Term Debt Volume apollomicsinc.com APLM|Company Current Liabilities Tharimmune Corp (THAR)|Amount of Current Liabilities Advanced Biomed Inc. ADVB|GNPX (Genprex, Inc.) - Company Short-Term Debts|CLDI: Short-Term Debt|SBFM (Sunshine Biopharma) - Company Short-Term Debt|XBIO (Xenetic Biosciences, Inc.) - Company Current Liabilities|SLRX: Company Short-Term Debt|Short-Term Debt Volume Kitov Pharma (PPBT)|American Oncology Network (AONC) - Company Current Liabilities|Company Short-Term Loans and Borrowings beigene.com (BGNE)|Company Short-Term Debts CKPT|Elevation Oncology Inc. - Short-Term Debt Volume|iCAD Corp (ICAD) - Company Short-Term Debt|IKNA - Company Short-Term Indebtedness|NTBL (Notable Labs, Ltd.) - Company Short-Term Debts|Company Current Liabilities Viracta Therapeutics, Inc.|MOR: Company Current Liabilities|Short-Term Debt Volume NAYA Biosciences Inc|Company Short-Term Debts Ascentage Pharma Group Ltd AAPGV